Status:
UNKNOWN
Observational Study of Survival Outcomes of Stage IV Cancer Patients
Lead Sponsor:
Cure Cancer Worldwide Corporation
Conditions:
Stage IV Cancer (Solid Tumors Only)
Survival
Eligibility:
All Genders
Brief Summary
Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemother...
Eligibility Criteria
Inclusion
- Presenting with Stage IV cancer (solid tumors only)
Exclusion
- Patient declines inclusion
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01843985
Start Date
June 1 2013
End Date
December 1 2018
Last Update
May 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yang Ling Demonstration Zone Hospital
Yangling, Shaanxi, China